Highly pathogenic avian influenza A(H5N1) virus of clade 2.3.4.4b isolated from a human case in Chile causes fatal disease and transmits between co-housed ferrets.

A(H5N1) avian influenza ferret transmission

Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
17 Mar 2024
Historique:
medline: 18 3 2024
pubmed: 18 3 2024
entrez: 18 3 2024
Statut: aheadofprint

Résumé

Clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses have caused large outbreaks within avian populations on five continents, with concurrent spillover into a variety of mammalian species. Mutations associated with mammalian adaptation have been sporadically identified in avian isolates, and more frequently among mammalian isolates following infection. Reports of human infection with A(H5N1) viruses following contact with infected wildlife have been reported on multiple continents, highlighting the need for pandemic risk assessment of these viruses. In this study, the pathogenicity and transmissibility of A/Chile/25945/2023 HPAI A(H5N1) virus, a novel reassortment with four gene segments (PB1, PB2, NP, MP) from North America lineage, isolated from a severe human case in Chile, was evaluated in vitro and using the ferret model. This virus possessed a high capacity to cause fatal disease, characterized by high morbidity and extrapulmonary spread in virus-inoculated ferrets. The virus was capable of transmission to naïve contacts in a direct contact setting, with contact animals similarly exhibiting severe disease, but did not exhibit productive transmission in respiratory droplet or fomite transmission models. Our results indicate that the virus would need to acquire an airborne transmissible phenotype in mammals to potentially cause a pandemic. Nonetheless, this work warrants continuous monitoring of mammalian adaptations in avian viruses, especially in strains isolated from humans, to aid pandemic preparedness efforts.

Identifiants

pubmed: 38494746
doi: 10.1080/22221751.2024.2332667
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2332667

Auteurs

Joanna A Pulit-Penaloza (JA)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Nicole Brock (N)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Jessica A Belser (JA)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Xiangjie Sun (X)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Claudia Pappas (C)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Troy J Kieran (TJ)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Poulami Basu Thakur (PB)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Hui Zeng (H)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Dan Cui (D)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Julia Frederick (J)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Rodrigo Fasce (R)

Viral Diseases Sub department, Public Health Institute, ISP, Santiago, Chile.

Terrence M Tumpey (TM)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Taronna R Maines (TR)

Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Classifications MeSH